Search results :

FK463

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J02AX05

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Gastrointestinal disorder Gastrointestinal disorder 32.1% - 100% x x x x x
Mediastinal disorder Mediastinal disorder 16.1% - 69.8% x x x x x
Malnutrition Malnutrition 37.8% - 41.1% x x x x x
Infection Infection 30.6% - 40.1% x
Infestation Infestation NOS 30.6% - 40.1% x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing, 14.3% - 79.2% x x x x x
Cardiac disorder Cardiac disorder 5.36% - 35.4% x x x x x
Nervous system disorder Nervous system disorder 10.5% - 20.8% x x x x x
Mental disorder Mental disorder 1.79% - 46.5% x x x x x
Hypokalaemia Hypokalaemia 14% - 16.8% x x x x
Vomiting Vomiting 2.5% - 66.7% x x x x x
Body temperature increased Body temperature increased 7% - 64.6% x x x x x
Neutropenia Neutropenia 5.36% - 76.7% x
Anaemia Anaemia 2.5% - 51.2% x x x x x
Anaemia NOS aggravated 2% - 4.95% x x
Dermatitis Rash 1.79% - 30.2% x x x x x
Rash Rash 1.79% - 30.2% x x x x x
Pruritus Pruritus 0% - 32.6% x x x x x
Diarrhoea Diarrhoea 7.14% - 64.6% x x x x x
Nausea Nausea 2.8% - 69.8% x x x x x
Epistaxis Epistaxis 0% - 16.7% x x x
Hypotension Hypotension 5.94% - 10% x x x x
Thrombocytopenia Thrombocytopenia 3.96% - 77.1% x x x x x
Anxiety Anxiety 0% - 23.3% x x x x
Abdominal distension Abdominal distension 1.79% - 18.6% x
Hypoglycaemia Hypoglycaemia 4.66% - 6.93% x x x
Oedema peripheral Oedema peripheral 5.5% - 7.25% x x x
Bacteraemia Bacteraemia 5% - 8.91% x x
Sepsis Sepsis 4.95% - 5.7% x x x
Insomnia Insomnia 3.96% - 8.29% x x x x
Alanine aminotransferase increased Alanine aminotransferase increased 0% - 16.3% x x x x x
Infusion related reaction Infusion related reaction 0% - 16.3% x
Tachycardia Tachycardia 1.79% - 25% x x x x x
Urticaria Urticaria 0% - 18.6% x x x x x
Headache Headache 2% - 5.7% x x x x x
Hypertension Hypertension 3% - 6.22% x x x x
Blood alkaline phosphatase increased Blood alkaline phosphatase increased 2.7% - 7.92% x x x x x
Febrile neutropenia Febrile neutropenia 0% - 16.3% x x x x
Decubitus ulcer Decubitus ulcer 4.5% - 5.94% x x
Septic shock Septic shock 4.46% - 7.5% x x
Abdominal pain Abdominal pain 1.98% - 34.9% x x x x x
Gastrointestinal pain Abdominal pain 1.98% - 34.9% x x x x x
Hypernatraemia Hypernatraemia 4% - 6.44% x x x
Bradycardia Bradycardia 2.5% - 4.95% x x x
Hyperkalaemia Hyperkalaemia 2.59% - 5% x x x x
Haematuria Haematuria 0% - 23.3% x
Oliguria Oliguria 0% - 23.3% x x x x
Urethral disorder Urinary tract disorder postmarketing, 7.14% - 37.2% x x x x x
Urinary tract disorder Urinary tract disorder postmarketing, 7.14% - 37.2% x x x x x
Hypomagnesaemia Hypomagnesaemia 0% - 8.42% x x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased 2.3% x x x x x
Pneumonia Pneumonia 1.5% - 5.45% x x x
Liver function test abnormal Liver function test abnormal 1.5% x x x x x
Atrial fibrillation Atrial fibrillation 0% - 4.95% x x x
Haemolytic anaemia Haemolytic anaemia postmarketing x x x x
Disseminated intravascular coagulation Disseminated intravascular coagulation postmarketing x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x x
Hyperbilirubinaemia Hyperbilirubinaemia postmarketing x x x x x
Renal failure acute Renal failure acute postmarketing x x x x
Liver disorder Liver disorder postmarketing x x x x
Hepatocellular injury Liver disorder postmarketing x x x x
Hepatocellular injury postmarketing x x x x x
Foetor hepaticus Liver disorder postmarketing x x x x
Shock Shock postmarketing x x x x x
Erythema multiforme Stevens-Johnson syndrome postmarketing x x
Erythema multiforme x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x
Angiopathy Angiopathy postmarketing, 18.7% - 23.3% x x x x x
Hepatic function abnormal Hepatic function abnormal postmarketing x x x x
Liver injury Hepatocellular injury postmarketing x x x x x
Hepatobiliary disease Hepatobiliary disease postmarketing x x x x x
White blood cell count decreased White blood cell count decreased postmarketing x x x
Renal failure Renal impairment postmarketing x x x x x
Renal failure x
Renal failure aggravated x
Renal impairment Renal impairment postmarketing x x x x x
Acidosis Acidosis x x x
Acquired immunodeficiency syndrome Acquired immunodeficiency syndrome x
Autoimmune disorder Acquired immunodeficiency syndrome x
Anaphylactic shock Anaphylactic shock x x
Anaphylactoid reaction x
Decreased appetite Anorexia x x x x
Decreased appetite 0% x x x
Anuria Anuria x x x
Apnoea Apnoea x x x
Arrhythmia Arrhythmia x x x
Arthralgia Arthralgia x x x
Musculoskeletal discomfort Arthralgia x x x
Aspergillus infection Aspergillosis x
Back pain Back pain x x
Coagulopathy Coagulopathy x x x x
Bone disorder Bone disorder x x x
Neoplasm malignant Neoplasm malignant x
Cholestasis Cholestasis x
Confusional state Confusional state x
Feeling abnormal Confusional state x
Connective tissue disorder Connective tissue disorder x x
Constipation Constipation x x x x
Cough Cough x x
Cyanosis Cyanosis x x x
Delirium Delirium x x x x
Dizziness Dizziness 0% x x x x
Dysgeusia Dysgeusia x x
Dyspepsia Dyspepsia x x x x
Dyspnoea Dyspnoea x x x x
Endocrine disorder Endocrine disorder x
Eosinophilia Eosinophilia 0% x x
Asthenia Fatigue 0% x x x
Fatigue Fatigue 0% x x x
Flushing Flushing x x x x
Cardiac arrest Cardiac arrest x x x x
Haemoglobinuria Haemoglobinuria x x x
Haemolysis Haemolysis x
Hepatitis Hepatitis x
Hepatomegaly Hepatomegaly x x x x x
Hiccups Hiccups x
Hyperglycaemia Hyperglycaemia x x
Hyperhidrosis Hyperhidrosis x
Hypersensitivity Hypersensitivity x x x
Hypocalcaemia Hypocalcaemia x x x x
Hyponatraemia Hyponatraemia x x x x
Immune system disorder Immune system disorder x x
Inflammation Inflammation x
Jaundice Jaundice x x x x x
Nephropathy Nephropathy x
Leukopenia Leukopenia x x
Lymphopenia Lymphopenia x
Fungal infection Fungal infection x
Myocardial infarction Myocardial infarction x x x x
Acute coronary syndrome Myocardial infarction x x x x
Palpitations Palpitations x
Pancytopenia Pancytopenia x x x x x
Pericardial effusion Pericardial effusion x
Phlebitis Phlebitis x x x x x
Pulmonary embolism Pulmonary embolism x x x
Thrombotic thrombocytopenic purpura Thrombotic thrombocytopenic purpura x x x x
Convulsion Convulsion x x x x
Thrombophlebitis Thrombophlebitis x x x x
Tremor Tremor x
Erythema Erythema x x x
Encephalopathy Encephalopathy x x x x
Hepatic failure Hepatic failure x x x x x
Hypophosphataemia Hypophosphataemia x x
Deep vein thrombosis Deep vein thrombosis x x x
Blood urea increased Blood urea increased x x
Drug level increased Drug level increased x
Swelling face Swelling face x x x x
Gamma-glutamyltransferase increased Gamma-glutamyltransferase increased x
Haemorrhage intracranial Haemorrhage intracranial x x x x
Injection site reaction Injection site reaction x x x x x
Skin necrosis Skin necrosis x x x
Skin exfoliation Skin necrosis x x x
Injection site pain Injection site pain x x
Abdominal pain upper Abdominal pain upper 0% x x x
Blood creatinine increased Blood creatinine increased x x
Hypoalbuminaemia Hypoalbuminaemia x
Fluid retention Fluid retention x x
Blood bilirubin increased Blood bilirubin increased x
Mucosal inflammation Mucosal inflammation x x
Anaphylactoid reaction Anaphylactoid reaction x
Haematological malignancy Haematological malignancy x
Chills Rigors 0% x x x x
Transaminases increased Transaminases increased x
Toxic skin eruption Toxic skin eruption x
Injection site thrombosis Injection site thrombosis x x x x x
Fluid overload Fluid overload x x
Blood lactate dehydrogenase increased Blood lactate dehydrogenase increased x x
Infusion site inflammation Infusion site inflammation x x
Renal tubular necrosis Renal tubular necrosis x x x
Somnolence Somnolence x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

micafungin / micafungin

Side effects:95
Source:EMA

MICAFUNGIN

Side effects:71
Source:FDA Structured Product Label

MICAFUNGIN SODIUM / MYCAMINE

Side effects:102
Source:FDA

MICAFUNGIN SODIUM / MYCAMINE

Side effects:109
Source:FDA

MICAFUNGIN SODIUM / MYCAMINE

Side effects:110
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label